NASDAQ
Deciphera Pharmaceuticals, Inc. (DCPH) has a free cash flow growth of -89.56% as of Friday, May 29, 2026. This represents a 4665.41% decrease compared to its 12-month average of 1.96%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.